ES2106838T3 - Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado. - Google Patents

Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado.

Info

Publication number
ES2106838T3
ES2106838T3 ES92311716T ES92311716T ES2106838T3 ES 2106838 T3 ES2106838 T3 ES 2106838T3 ES 92311716 T ES92311716 T ES 92311716T ES 92311716 T ES92311716 T ES 92311716T ES 2106838 T3 ES2106838 T3 ES 2106838T3
Authority
ES
Spain
Prior art keywords
release
dispersion
pharmacy
hydration
gelatinous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92311716T
Other languages
English (en)
Inventor
Gerald S Rork
James D Pipkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2106838T3 publication Critical patent/ES2106838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN DISPOSITIVO PARA EL SUMINISTRO CONTROLADO DE UN AGENTE BENEFICIOSO TAL COMO UNA DISPERSION GELATINOSA QUE CONSTA DE I) UN NUCLEO QUE CONTIENE UN AGENTE BENEFICIOSO, UN POLIMERO QUE FORMA PARTICULAS MICROSCOPICAS GELATINOSAS DESPUES DE SU HIDRATACION Y SI SE DESEA UN AGENTE PARA MODULAR LA HIDRATACION DEL POLIMERO; Y II) UN RECUBRIMIENTO INSOLUBLE E IMPERMEABLE QUE SE ADHIERE Y RODEA EL NUCLEO Y CONTIENE APERTURAS QUE SUMINISTRAN UN AREA PARA LA HIDRATACION Y LIBERACION DE UNA DISPERSION QUE COMPRENDA PARTICULAS MICROSCOPICAS GELATINOSAS.
ES92311716T 1991-12-27 1992-12-22 Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado. Expired - Lifetime ES2106838T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (1)

Publication Number Publication Date
ES2106838T3 true ES2106838T3 (es) 1997-11-16

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92311716T Expired - Lifetime ES2106838T3 (es) 1991-12-27 1992-12-22 Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado.

Country Status (26)

Country Link
EP (1) EP0549331B1 (es)
JP (1) JPH089534B2 (es)
KR (1) KR100281609B1 (es)
CN (1) CN1074368A (es)
AT (1) ATE157001T1 (es)
AU (1) AU660057B2 (es)
BG (1) BG61751B1 (es)
CA (1) CA2085871C (es)
CZ (1) CZ284045B6 (es)
DE (1) DE69221711T2 (es)
DK (1) DK0549331T3 (es)
ES (1) ES2106838T3 (es)
FI (1) FI109451B (es)
GR (1) GR3024885T3 (es)
HU (1) HU219594B (es)
IL (1) IL104189A (es)
LV (1) LV12082B (es)
MX (1) MX9207541A (es)
NO (1) NO310672B1 (es)
NZ (1) NZ245514A (es)
PL (1) PL171110B1 (es)
RO (1) RO112810B1 (es)
RU (1) RU2127586C1 (es)
SK (1) SK279964B6 (es)
WO (1) WO1993012765A1 (es)
YU (1) YU48762B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
ES2175676T3 (es) * 1997-01-14 2002-11-16 Lohmann Therapie Syst Lts Sistema terapeutico expansible de retencion gastrica con liberacion controlada de principio activo en el tracto gastrointestinal.
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
ATE244558T1 (de) 1999-04-16 2003-07-15 Novo Nordisk As Trockene formbare arzneistoffformulierung
CN1214792C (zh) 2000-08-08 2005-08-17 第一制药株式会社 吸收性很好的固体制剂
WO2002055009A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2003055467A1 (en) * 2001-12-18 2003-07-10 Synthon B.V. Simvastatin dosage forms
JP4615862B2 (ja) * 2001-12-18 2011-01-19 ノボ・ノルデイスク・エー／エス 固形投与マイクロインプラント
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
CA2499882C (en) * 2002-09-28 2010-11-09 Mcneil-Ppc, Inc. Modified release dosage form with two cores
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP3470108A1 (en) 2004-07-02 2019-04-17 Mati Therapeutics Inc. Treatment medium delivery device for delivery of treatment media to the eye
BRPI0709672B8 (pt) 2006-03-31 2021-06-22 3088922 Inc implante ocular insersível em um lúmen ocular e método de distribuição de um agente terapêutico a um olho
AU2008300022A1 (en) 2007-09-07 2009-03-19 Qlt Inc. Lacrimal implant detection
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP3290024B1 (en) 2011-08-29 2019-04-17 Mati Therapeutics Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
EP0549331B1 (en) 1997-08-20
BG98805A (bg) 1995-03-31
YU111292A (sh) 1995-12-04
RU2127586C1 (ru) 1999-03-20
MX9207541A (es) 1994-06-30
LV12082A (lv) 1998-07-20
EP0549331A1 (en) 1993-06-30
IL104189A0 (en) 1993-05-13
CA2085871C (en) 2002-05-07
RU94031474A (ru) 1997-04-20
AU660057B2 (en) 1995-06-08
DE69221711D1 (de) 1997-09-25
KR100281609B1 (ko) 2001-02-15
ATE157001T1 (de) 1997-09-15
NO942430D0 (no) 1994-06-27
DE69221711T2 (de) 1998-03-12
CN1074368A (zh) 1993-07-21
JPH05255071A (ja) 1993-10-05
SK76994A3 (en) 1995-05-10
HU219594B (hu) 2001-05-28
PL171110B1 (pl) 1997-03-28
BG61751B1 (bg) 1998-05-29
CA2085871A1 (en) 1993-06-28
FI943011A (fi) 1994-06-22
NO942430L (no) 1994-06-27
FI109451B (fi) 2002-08-15
IL104189A (en) 1996-10-31
FI943011A0 (fi) 1994-06-22
YU48762B (en) 1999-11-22
WO1993012765A1 (en) 1993-07-08
RO112810B1 (ro) 1998-01-30
SK279964B6 (sk) 1999-06-11
AU3034892A (en) 1993-08-12
CZ284045B6 (cs) 1998-07-15
DK0549331T3 (da) 1997-09-15
JPH089534B2 (ja) 1996-01-31
HU9401913D0 (en) 1994-09-28
CZ157094A3 (en) 1994-12-15
NO310672B1 (no) 2001-08-13
GR3024885T3 (en) 1998-01-30
HUT70437A (en) 1995-10-30
LV12082B (en) 1998-09-20
KR940703653A (ko) 1994-12-12
NZ245514A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ES2106838T3 (es) Dispositivo de liberacion en dispersion de un farmaco de liberacion controlado.
EP0801560A4 (en) DEVICE FOR CONTROLLED RELEASE OF A DRUG SUSPENSION
FI973411A (fi) Rakenne geelisäiliöksi
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
DK0494943T3 (da) Interaktivt system til anvendelse ved lokalt indgreb inde i en ikke homogen struktur
AU6421594A (en) High release solid preparation, preparation and use thereof
CA2222359A1 (fr) Composition cosmetique comprenant l'association d'un polymere filmogene et d'une dispersion de cire et utilisation de ladite association
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
EP0458481A3 (en) Polymeric film
DE69419314D1 (en) Orthopädisches material
FR2656919B2 (fr) Dispositif d'utilisation de corps spongieux pour humidification d'air chaud.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549331

Country of ref document: ES